DMD INTERNET

dmd-internet-logo

DMD Internet is a Web Design company.

#Website #More

DMD INTERNET

Social Links:

Industry:
Web Design

Founded:
1996-01-01

Address:
Auckland, Auckland, New Zealand

Country:
New Zealand

Website Url:
http://www.dmd.co.nz

Total Employee:
11+

Status:
Closed

Contact:
+64 3 520 8193

Email Addresses:
[email protected]

Technology used in webpage:
Domain Not Resolving IPv6 Google Apps For Business Cloudflare Hosting Cloudflare DNS


Official Site Inspections

http://www.dmd.co.nz

  • Host name: 104.21.51.89
  • IP address: 104.21.51.89
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "DMD Internet"

Parent Project Muscular Dystrophy (PPMD)

Parent Project Muscular Dystrophy fights to end Duchenne. We accelerate research, raise our voices to impact policy, demand optimal care for every single family, and strive to ensure โ€ฆSee details»

Home World Duchenne Organization โ€ข World Duchenne

The World Duchenne Organization is here to support you in every way imaginable: with information about the condition, where to go and what to do for care, research, clinical trials, and advocacy. By doing this, we hope to โ€ฆSee details»

Organizations - DMD RESOURCES

Hunter's Heart Foundation Hunter's Heart Foundation is a non-profit organization dedicated to enriching the lives of children battling Duchenne Muscular Dystrophy (DMD). We achieve this โ€ฆSee details»

A Non-Profit Works to Advance a DMD Gene Therapy

Nov 21, 2024 Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organizationโ€™s efforts to complete clinical development of its gene therapy for the condition, โ€ฆSee details»

Call of interest: Global DMD Adult Group โ€ข World Duchenne

Jun 11, 2024 In collaboration with the World Duchenne Organization, the group intends to explore themes such as independence, relationships, and navigating life transitions. Currently, โ€ฆSee details»

duchennemd.org

Upon approval, Santhera intends to commercialize vamorolone for the treatment of DMD through its own organization in the United States and main markets in Europe, and is seeking collaborations outside those regions for DMD and for โ€ฆSee details»

Home - Duchenne Data Foundation

Bringing data to life to improve the lives of people with Duchenne and Becker muscular dystrophy. This it the goal of Duchenne Data FoundationSee details»

What is Duchenne? โ€ข World Duchenne Awareness Day

One in 5000 newborn boys in the world is affected by a rare and fatal disease: Duchenne Muscular Dystrophy (DMD). Seems like a small group, but the 250.000 patients around the globe think big and have big dreams. Duchenne Parents โ€ฆSee details»

CINRG Duchenne Natural History

Duchenne Natural History The Cooperative International Neuromuscular Research Group (CINRG) has established the largest prospective multicenter natural history study to date in Duchenne muscular dystrophy (DMD), the โ€ฆSee details»

Home | DMD Hub

The DMD Hub Toolkit is a selection of expanding resources for industry and research sites aimed at upskilling sites and offering pragmatic support in trial set, thereby promoting a common โ€ฆSee details»

Current and emerging treatment strategies for Duchenne muscular ...

Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in childhood. It is caused by mutations of the DMD gene, leading to progressive muscle โ€ฆSee details»

Research - Duchenne Muscular Dystrophy (DMD)

In Duchenne muscular dystrophy (DMD), muscle is missing a key structural protein called dystrophin, making it more susceptible to injury. Eventually the body cannot keep up with โ€ฆSee details»

Global epidemiology of Duchenne muscular dystrophy: an โ€ฆ

Jun 5, 2020 Duchenne Muscular Dystrophy (DMD) is a rare neuromuscular X-linked disorder that belongs to a group of disorders known as dystrophinopathies. DMD is caused by โ€ฆSee details»

Muscular Dystrophy News Home | Muscular Dystrophy News

The U.S. Food and Drug Administration (FDA) has accepted Capricor Therapeuticsโ€™ application seeking approval of deramiocel โ€” a cell therapy developed by the biotech company to treat โ€ฆSee details»

The TREAT-NMD DMD Global Database: Analysis of More than โ€ฆ

Abstract Analyzing the type and frequency of patient-specific mutations that give rise to Duchenne muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research, trial โ€ฆSee details»

Therapeutic approaches for Duchenne muscular dystrophy

Aug 31, 2023 Duchenne muscular dystrophy (DMD) is a monogenic muscle-wasting disorder and a priority candidate for molecular and cellular therapeutics. Although rare, it is the most โ€ฆSee details»

Over 3500 Dads Give Back To Local Charity Through โ€œDMD Gives โ€ฆ

Aug 22, 2018 The international organization, Dads Married to Doctors (DMD), is made up of over 3,500 dads in 25+ countries who want to give back in a big way through the DMD Gives โ€ฆSee details»

The burden, epidemiology, costs and treatment for Duchenne โ€ฆ

Apr 26, 2017 Background Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal neuromuscular disorder, present from birth, which occurs almost exclusively in males. We โ€ฆSee details»

Organizations - Search - D&D Beyond

Organizations In eras past, when Krynn faced times of exceptional darkness, champions stepped forth from the ranks of the virtuous Knights of Solamnia and the mystical Mages of High โ€ฆSee details»